GlassScriptPhysician profile
Samuel M Riddle
NPI 1134188238
$554.63
in general payments reported to CMS, 2019-2025
16 companies · $61.09 in 2025
The $61.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2021: $25.60 · 2023: $120 · 2024: $97.25 · 2025: $61.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $124.93 | 2019 | |
| Sumitomo Pharma America, INC. | $74.66 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $49.28 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Kerecis Limited | $45.30 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Duchesnay USA Incorporated | $43.20 | 2019 | |
| Amag Pharmaceuticals, INC. | $37.76 | 2019 | |
| Aspira Women'S Health INC | $26.87 | 2023 | Ova1 |
| Dompe US, INC. | $23.04 | 2025 | Oxervate |
| Hydrofera LLC | $22.67 | 2025 | Leukomed Sorbact |
| Astellas Pharma US INC | $19.70 | 2024 | Veozah |
| Organon LLC | $16.45 | 2024 | |
| Merck Sharp & Dohme LLC | $15.98 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.75 | 2019 | |
| Agile Therapeutics, INC. | $14.13 | 2021 | |
| Therapeuticsmd, INC. | $13.44 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.